This review explores the limited but evolving evidence on menopause in women with T1DM, including age of onset, changes in glycaemic control and insulin requirements, and the effects on bone, metabolic, and cardiovascular health, as well as breast cancer risk and psychological well-being. This evidence concerns the gene INS and breast cancer.